Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wölfel

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Cancer Research and Clinical Oncology|April 7, 2004
Immunotherapy of cancer: from vision to standard clinical practiceChristoph H Huber, Thomas Wölfel
Onkologie|June 26, 2013
[Immune oncology in focus]Thomas Wölfel, Jürgen C Becker, Michael Schmitt
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2Julia Steitz, Cedrik M Britten, Thomas Wölfel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysisMiran Javorovic, Heike Pohla, Bernhard Frankenberger, et al.
Vaccine|May 15, 2007
Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigenRalf G Meyer, Claudine Graf, Cedrik M Britten, et al.
Journal of Immunological Methods|April 22, 2004
The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assaysCedrik M Britten, Ralf G Meyer, Nadine Frankenberg, et al.
Journal of Immunological Methods|May 26, 2005
Identification of T cell epitopes by the use of rapidly generated mRNA fragmentsCedrik M Britten, Ralf G Meyer, Claudine Graf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Identification of HLA-A*0201-restricted T cell epitopes derived from the novel overexpressed tumor antigen calcium-activated chloride channel 2Renate Konopitzky, Ulrich König, Ralf G Meyer, et al.
Journal of Immunological Methods|December 4, 2001
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assaysCedrik M Britten, Ralf G Meyer, Tanja Kreer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2007
An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancerRalf G Meyer, Stephanie Korn, Patrick Micke, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Cancer Research and Clinical Oncology|April 7, 2004
Immunotherapy of cancer: from vision to standard clinical practiceChristoph H Huber, Thomas Wölfel
Onkologie|June 26, 2013
[Immune oncology in focus]Thomas Wölfel, Jürgen C Becker, Michael Schmitt
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2Julia Steitz, Cedrik M Britten, Thomas Wölfel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysisMiran Javorovic, Heike Pohla, Bernhard Frankenberger, et al.
Vaccine|May 15, 2007
Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigenRalf G Meyer, Claudine Graf, Cedrik M Britten, et al.
Journal of Immunological Methods|April 22, 2004
The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assaysCedrik M Britten, Ralf G Meyer, Nadine Frankenberg, et al.
Journal of Immunological Methods|May 26, 2005
Identification of T cell epitopes by the use of rapidly generated mRNA fragmentsCedrik M Britten, Ralf G Meyer, Claudine Graf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Identification of HLA-A*0201-restricted T cell epitopes derived from the novel overexpressed tumor antigen calcium-activated chloride channel 2Renate Konopitzky, Ulrich König, Ralf G Meyer, et al.
Journal of Immunological Methods|December 4, 2001
The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assaysCedrik M Britten, Ralf G Meyer, Tanja Kreer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2007
An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancerRalf G Meyer, Stephanie Korn, Patrick Micke, et al.
Pageof 4